The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine ...

NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

The following is a summary of “Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind ...

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...